DK185079A - Azolopyrimidinoner og fremgangsmaade til fremstilling deraf - Google Patents

Azolopyrimidinoner og fremgangsmaade til fremstilling deraf

Info

Publication number
DK185079A
DK185079A DK185079A DK185079A DK185079A DK 185079 A DK185079 A DK 185079A DK 185079 A DK185079 A DK 185079A DK 185079 A DK185079 A DK 185079A DK 185079 A DK185079 A DK 185079A
Authority
DK
Denmark
Prior art keywords
azolopyrimidinons
preparation
Prior art date
Application number
DK185079A
Other languages
Danish (da)
English (en)
Inventor
R R Covington
D L Temple
J P Yevich
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of DK185079A publication Critical patent/DK185079A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/14Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/42Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/68Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
DK185079A 1978-05-05 1979-05-04 Azolopyrimidinoner og fremgangsmaade til fremstilling deraf DK185079A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/903,265 US4223031A (en) 1978-05-05 1978-05-05 Azolopyrimidinones

Publications (1)

Publication Number Publication Date
DK185079A true DK185079A (da) 1979-11-06

Family

ID=25417203

Family Applications (1)

Application Number Title Priority Date Filing Date
DK185079A DK185079A (da) 1978-05-05 1979-05-04 Azolopyrimidinoner og fremgangsmaade til fremstilling deraf

Country Status (18)

Country Link
US (1) US4223031A (de)
JP (1) JPS54145696A (de)
AU (1) AU528715B2 (de)
BE (1) BE876059A (de)
CA (1) CA1109870A (de)
CH (2) CH641460A5 (de)
DE (1) DE2918085A1 (de)
DK (1) DK185079A (de)
FI (1) FI65260C (de)
FR (1) FR2424924A1 (de)
GB (1) GB2020654B (de)
GR (1) GR72717B (de)
IE (1) IE47976B1 (de)
LU (1) LU81231A1 (de)
NL (1) NL7903535A (de)
SE (2) SE445642B (de)
YU (1) YU103679A (de)
ZA (1) ZA792130B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4491587A (en) * 1978-05-05 1985-01-01 Mead Johnson & Company Tetrazole derivatives
US4297355A (en) * 1979-11-15 1981-10-27 Schering Corporation (1H,3H,5H)-(1)-Benzopyrano-(2,3-d)-pyrimidine-4-one-2-thiones and their use as anti-allergy agents
US4414388A (en) * 1979-11-23 1983-11-08 Pfizer Inc. 1-Oxo-1H-thiazolo[3,2-a]pyrimidine-2-carboxamides
DK151811C (da) * 1979-11-23 1988-06-06 Pfizer Analogifremgangsmaade til fremstilling af n-(5-tetrazolyl)-1-oxo-1h-thiazolooe3,2-aaa-pyrimidin-2-carboxamider eller farmaceutisk acceptable kationsalte deraf samt 1-oxo-1h-thiazolooe3,2-aaapyrimidin-2-carboxylsyrer til anvendelse som udgangsmaterialer ved fremgangsmaaden
JPS57165318A (en) * 1981-04-03 1982-10-12 Mochida Pharmaceut Co Ltd Remedy for asthma
US4510143A (en) * 1982-02-17 1985-04-09 Roussel Uclaf Antiallergic pyrimido[1,2-a]quinoxalin-2-carboxylic acid derivatives
IL69417A (en) * 1982-08-27 1987-12-20 Roussel Uclaf 2-acyl imidazo(1,2-a)pyrimidines,their preparation and pharmaceutical compositions containing them
US4476130A (en) * 1982-09-09 1984-10-09 Riker Laboratories, Inc. 3-(1H-Tetrazol-5-yl)-4H-pyrimido[2,1-b]benzoxazol-4-one compounds exhibiting anti-allergic activity
US4507477A (en) * 1982-09-09 1985-03-26 Riker Laboratories, Inc. Process for tetrazolyl-pyrimidinone derivatives
US4474953A (en) * 1982-09-09 1984-10-02 Riker Laboratories, Inc. Process and intermediates for the preparation of 3(1H-tetrazol-5-yl)-4H-pyrido[1,2-a]pyrimidin-4-ones
GB8300728D0 (en) * 1983-01-12 1983-02-16 Erba Farmitalia Substituted carboxy-thiazolo / 3 2 - a / pyrimidine derivatives
GB8334210D0 (en) * 1983-12-22 1984-02-01 Roussel Lab Ltd Imidazo(1 2-c)pyrimidines
US4762840A (en) * 1984-02-13 1988-08-09 Roussel Uclaf Pyrimido[2,1-b]benzothiazoles having antiallergic activity
JPS60226887A (ja) * 1984-04-25 1985-11-12 Dai Ichi Seiyaku Co Ltd トリアゾロピリミジン誘導体
GB8422918D0 (en) * 1984-09-11 1984-10-17 May & Baker Ltd Compositions of matter
GB8422916D0 (en) * 1984-09-11 1984-10-17 May & Baker Ltd Compositions of matter
CA1270840A (en) * 1985-01-29 1990-06-26 Wolfgang Wehner Triazole derivatives and the use thereof for stabilising organic polymers
IL78017A (en) * 1986-03-03 1989-06-30 Yissum Res Dev Co Sustained release tablets of theophylline
JPS6357522A (ja) * 1986-08-28 1988-03-12 Mect Corp ピリミド〔2,1−d〕ベンゾチアゾ−ル誘導体からなる血小板凝集抑制剤
IL85207A (en) * 1987-02-06 1992-06-21 Daiichi Seiyaku Co 6-substituted thiazolo-(and 1,3,4-thiadiazolo-)(3,2-a)-(1,2,3)triazolo(4,5-d)pyrimidin-9(1h)-ones and their preparation
US8349846B2 (en) * 2008-01-11 2013-01-08 Glenmark Pharmaceuticals, S.A. Fused pyrimidine derivatives as TRPV3 modulators
US8119647B2 (en) * 2008-04-23 2012-02-21 Glenmark Pharmaceuticals S.A. Fused pyrimidineone compounds as TRPV3 modulators

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1070243A (en) * 1964-07-15 1967-06-01 Smith Kline French Lab S-triazolopyrimidones, their preparation and compositions containing them
CH491944A (de) * 1966-11-29 1970-06-15 Ciba Geigy Verfahren zur Herstellung von benzheterocyclischen Verbindungen
IE33549B1 (en) * 1968-09-13 1974-08-07 Ici Ltd S-triazolo (1,5-a) pyrimidine derivatives
US3888983A (en) * 1970-08-14 1975-06-10 Seperic Derivatives of thiazolino-pyrimidin-6-ones, in inducing analgesia
US3907799A (en) * 1971-08-16 1975-09-23 Icn Pharmaceuticals Xanthine oxidase inhibitors
US4033961A (en) * 1975-10-07 1977-07-05 Warner-Lambert Company Pyrido[2-1-b]quinazolin-ones and their methods of preparation
DE2557425A1 (de) * 1975-12-19 1977-06-30 Boehringer Sohn Ingelheim Chinazolonderivate
US4041163A (en) * 1976-03-29 1977-08-09 Pfizer Inc. N-(5-Tetrazolyl)-4-oxo-4H-pyrimido(2,1-b)benzothiazole-3-carboxamide antiallergy agents
US4072679A (en) * 1976-06-15 1978-02-07 E. R. Squibb & Sons, Inc. 1,4- AND 4,10-DIHYDRO-4-OXO-PYRIMIDO (1,2-A)-benzimidazole-3-carboxylic acids, esters and amides
US4122274A (en) * 1977-05-25 1978-10-24 Bristol-Myers Company 3-Tetrazolo-5,6,7,8-substituted-pyrido[1,2-a]pyrimidin-4-ones

Also Published As

Publication number Publication date
GB2020654A (en) 1979-11-21
AU4666779A (en) 1979-11-22
JPS54145696A (en) 1979-11-14
ZA792130B (en) 1980-06-25
GR72717B (de) 1983-12-01
YU103679A (en) 1983-02-28
AU528715B2 (en) 1983-05-12
US4223031A (en) 1980-09-16
SE8404151L (sv) 1984-08-20
FI791411A (fi) 1979-11-06
SE8404151D0 (sv) 1984-08-20
FR2424924A1 (fr) 1979-11-30
DE2918085A1 (de) 1979-11-15
BE876059A (fr) 1979-11-05
FI65260B (fi) 1983-12-30
IE47976B1 (en) 1984-08-08
SE7903927L (sv) 1979-11-06
CA1109870A (en) 1981-09-29
LU81231A1 (fr) 1979-12-06
NL7903535A (nl) 1979-11-07
CH641460A5 (de) 1984-02-29
IE790912L (en) 1979-11-05
SE445642B (sv) 1986-07-07
GB2020654B (en) 1982-08-04
CH651300A5 (de) 1985-09-13
FR2424924B1 (de) 1983-01-14
FI65260C (fi) 1984-04-10

Similar Documents

Publication Publication Date Title
DK223779A (da) Oligomere methacrylsubstituerede alkylsiloxaner og fremgangsmaade til fremstilling deraf
DK185079A (da) Azolopyrimidinoner og fremgangsmaade til fremstilling deraf
DK137378A (da) Taeppe og fremgangsmaade til fremstilling deraf
DK396079A (da) Tekstilline og fremgangsmaade til fremstilling deraf
DK248078A (da) Phatalaziner og fremgangsmaade til fremstilling deraf
DK372878A (da) Thiadiazolylcephalosporinanaloge og fremgangsmaade til fremstilling deraf
NO793836L (no) Fremgangsmaate og innretning for boeyning av glassplater
NO774429L (no) Munnpleiepreparat og fremgangsmaate ved fremstilling derav
DK149842C (da) Fremgangsmaade til fremstilling af d-camphorat af l-carnitinamid og d-camphorat af d-carnitinamid
NO791682L (no) Fornettbare copolymerer og fremgangsmaate ved fremstilling derav
DK132779A (da) Fremgangsmaade til fremstilling af cishexahydrodibenzoepyranoner og tetrahydrobenzoxoiner
DK39179A (da) 2h-benzofuran-3-on-derivater og fremgangsmaade til fremstilling deraf
DK308578A (da) Meningokokvaccine og fremgangsmaade til fremstilling heraf
DK151267C (da) Xanthanase og fremgangsmaade til fremstilling og anvendelse deraf
DK565981A (da) Kommutator og fremgangsmaade til fremstilling deraf
DK96177A (da) 4-androsten-3-oner og fremgangsmade til fremstilling heraf
DK12478A (da) Dithienylalkylaminer og fremgangsmaade til fremstilling deraf
IT1120002B (it) Metodo e procedimento per arilalchilazione
ES487982A0 (es) Metodo de preparar 3-0-(beta-d-glucuronopiranosil)-sojasapo-genol b y similares
DK554078A (da) Tetrapeptider og fremgangsmaade til fremstilling deraf
DK121279A (da) Demethylmaytansinoider og fremgangsmaade til fremstilling deraf
DK224279A (da) Polyjodbenzenderivater og fremgangsmaade til fremstilling deraf
DK270279A (da) Cystaminderivater og fremgangsmaade til fremstilling deraf
DK151570C (da) Afsvovlningsmiddel og fremgangsmaade til fremstilling deraf
NO151460C (no) Fremgangsmaate og fremstilling av 2-fluorerte metylaminoacetonitriler

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment